Eli Lilly and Company (NYSE:LLY) recently announced the availability of its radioactive diagnostic agent, Amyvid (florbetapir F 18 Injection), in certain markets in the US. The company said that Amyvid is available in imaging centers at markets in the vicinity of 16 manufacturing sites. Eli Lilly has also launched an online training program.
The US Food and Drug Administration (FDA) had approved Amyvid in April 2012. Amyvid has been designed to help detect the density of beta-amyloid plaques in … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards